Apollo Hospitals' efforts to ramp-up occupancy levels and average revenue per occupied bed is expected to drive solid earnings growth in Q3, which usually remains a seasonally weak quarter for hospital majors.

Apollo Hospitals Q4 preview: Steady hospital business, healthy growth in HealthCo to aid earnings expansion

Improved performance from Apollo Hospitals' online business, Apollo HealthCo, and strong seasonality for its flagship hospital business is expected to drive earnings growth in Q4.

Apollo Hospitals Q1 Preview: Losses from Apollo HealthCo to drag earnings

While losses in the company's Apollo HealthCo arm are likely to moderate sequentially, they will still remain elevated on the year-on-year basis.

Apollo Hospitals Q1 PAT seen up 1.5% YoY to Rs. 246.76 cr: ICICI Direct

Net Sales are expected to increase by 3.7 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs. 3,898 crore, according to ICICI Direct.

Apollo Hospitals Enterprise Q1 PAT may dip 14.2% YoY to Rs 167.4 cr: Prabhudas Lilladher

Net Sales are expected to decrease by 0.3 percent Y-o-Y (up 5.7 percent Q-o-Q) to Rs 3,747.7 crore, according to Prabhudas Lilladher.

Apollo Hospitals Q4 PAT seen up 43.4% YoY to Rs. 215.66 cr: ICICI Direct

Net Sales are expected to increase by 26 percent Y-o-Y (down 0.7 percent Q-o-Q) to Rs. 3,613 crore, according to ICICI Direct.

Apollo Hospitals Q3 PAT seen up 100.7% YoY to Rs. 261.8 cr: ICICI Direct

Net Sales are expected to increase by 31.1 percent Y-o-Y (down 2.7 percent Q-o-Q) to Rs. 3,616.8 crore, according to ICICI Direct.

Apollo Hospitals Q1 PAT may dip 167.4% YoY to Rs 140.2 cr: ICICI Direct

Net Sales are expected to increase by 27.7 percent Y-o-Y (down 3.3 percent Q-o-Q) to Rs 2,772.3 crore, according to ICICI Direct.

Apollo Hospitals Q2 PAT seen up 111.5% YoY to Rs. 130.9 cr: Kotak

Net Sales are expected to increase by 16.1 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 2,787.1 crore, according to Kotak.

Apollo Hospitals Q1 PAT seen up 170.7% YoY to Rs. 95 cr: Kotak

Net Sales are expected to increase by 17.7 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 2,594.8 crore, according to Kotak.

Apollo Hospitals Q4 PAT seen up 45.7% YoY to Rs. 52 cr: Kotak

Net Sales are expected to increase by 17.3 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 2,475.3 crore, according to Kotak.

Apollo Hospitals Q3 PAT seen up 38.4% YoY to Rs. 93.3 cr: ICICI Direct

Net Sales are expected to increase by 13.2 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 2,145.8 crore, according to ICICI Direct.

Apollo Hospitals Q2 PAT seen up 37.4% YoY to Rs. 97.4 cr: ICICI Direct

Net Sales are expected to increase by 13 percent Y-o-Y (up 9.5 percent Q-o-Q) to Rs. 2,092.4 crore, according to ICICI Direct.

Apollo Hospitals Q4 PAT seen up 47.8% YoY to Rs 71.2 cr: Edelweiss

Net Sales are expected to increase by 14 percent Y-o-Y to Rs. 1894.3 crore, according to Edelweiss.

Aim to have close to 3000 pharmacies by end of this year: Apollo Hospital

Apollo Hopsitals' Q3 earnings were in line with street estimates but profit was impacted due to higher depreciation and finance costs on account of new hospitals like Navi Mumbai coming on stream. In an interview with CNBC-TV18, Akhileshwaran Krishnan, CFO of Apollo Hospital spoke about the results and his outlook for the company.

Occupancies for hospital biz at 68%; mature hospital occupancy at 71%: Apollo Hospitals

Apollo Hospitals reported an over 20 percent dip in the bottomline this quarter. In an interview with CNBC-TV18, Suneeta Reddy, MD of the company discussed the earnings fine print.

Apollo Hospitals Q2 PAT may dip 53% YoY to Rs. 30 cr: Kotak

Net Sales are expected to increase by 14 percent Y-o-Y (up 10.4 percent Q-o-Q) to Rs. 2101.9 crore, according to Kotak.

Added 150 beds in Navi Mumbai unit; 100 occupied currently: Apollo Hospitals

In an interview to CNBC-TV18, Suneeta Reddy, MD of Apollo Hospitals Enterprises discussed the company's Q1 performance.

Will not raise more debt, not looking at acquisition currently: Apollo Hospitals

In an interview to CNBC-TV18, Suneeta Reddy, MD of Apollo Hospitals Enterprises spoke about the results and her outlook for the company.

Apollo Hospitals upbeat on Q4; sees EBITDA margins around 12%

Apollo Hospitals Chief Financial Officer Krishnan Akhileswaran said the pharmacy business got a boost from demonetisation because people were allowed to use their old notes (Rs 500, Rs 1000).

Focus on restructuring to ensure growth of all verticals: Apollo

The company has incubated many businesses and its Chennai cluster saw 2 percent growth this quarter, says Suneeta Reddy, MD , Apollo Hospital.

Apollo Hospitals Q1 PAT seen down 8.8% to Rs 69 cr: Edelweiss

Net Sales are expected to increase by 1.5 percent Q-o-Q (up 12 percent Y-o-Y) to Rs 1416.8 crore, according to Edelweiss

Pharmacy sales to grow at 25%; eye acquisitions: Apollo Hospital

Apollo‘s pharmacy business saw a slight rise in margins to 3.6 percent and its private label grew 6.7 percent with higher margins.

See pharmacy growing at 25-30% going forward: Apollo Hospitals

Krishnan Akhileswaran, CFO of Apollo Hospitals, says Rs 85 crore worth revenue came from new hospitals and the company saw an 8 percent volume growth in the third quarter.

Apollo Hospitals Q3 profit seen up 1.9%, revenue may rise 26%

Operating profit (earnings before interest, tax, depreciation and amortisation) in Q3 is seen rising 14 percent to Rs 180 crore but margin may contract 150 basis points to 14.4 percent compared to year-ago period.